Cytox is developing a diagnostic test and therapeutic cures for Alzheimer’s Disease which is estimated to affect 15 million people worldwide. The company is a university spin-out based on groundbreaking academic research into the role of the cell cycle in neuro-degenerative diseases.

Status current

Associated Fund Advantage Growth Fund,
UK Innovation & Science Seed Fund

Sector Medical / Biotechnology


Associated Team Members

Relevant News

Cytox Plans US Clinical Launch for Early-Stage Alzheimer's Test While Courting Pharma Partners

  May 03, 2017 Justin Petrone British molecular diagnostics company Cytox plans to make…

read more


Work With Us... Working with Cytox · Contact · Search: Newsletters. Newsletters. Newsletter...

read more

Cardiff University and Cytox to present further results on the...

CONTACT: Cytox Limited. Richard Pither, CEO. +44(0)1865338018. KEYWORD: UNITED ...

read more

More Companies in Medical / Biotechnology